Improvement in clinical outcome and infection control using molecular diagnostic techniques for early detection of MDR tuberculous spondylitis: a multicenter retrospective study

References

• World Health OrganizationGlobal Tuberculosis Control 2014.Geneva: WHO.2014.
   Google Scholar
• Kipiani M, Mirtskhulava V, Tukvadze Net al.Significant clinical impact of a rapid molecular diagnostic test (genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis. Clin Infect Dis 2014;59: 1559–1566.
   PubMed Web of Science ®Google Scholar
• Rüsch S, Gaby E, Casal M.Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006;44: 688–692.
   PubMedGoogle Scholar
• Gu Y, Wang G, Dong Wet al.Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis. Int J Infect Dis 2015;36: 27–30.
   PubMed Web of Science ®Google Scholar
• Li R, Ruan Y, Sun Qet al.Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study. Lancet Glob Health 2015;3: e217–e228.
   PubMed Web of Science ®Google Scholar
• Nathavitharana RR, Hillemann D, Schumacher SGet al.Multicenter noninferiority evaluation of Hain GenoType MTBDRplus version 2 and Nipro NTM+MDRTB line probe assays for detection of rifampin and isoniazid resistance. J Clin Microbiol 2016;54: 1624–1630.
   PubMed Web of Science ®Google Scholar
• Javed N, Aslam M, Mushtaq MAet al.Role of gene Xpert in diagnosis of tuberculous pleural effusion: comparison with pleural biopsy. Eur Respir J 2014;44: 2655.
   Web of Science ®Google Scholar
• Boehme CC, Nicol MP, Nabeta P.Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicenter implementation study. Lancet 2011;377: 1495–1505.
   PubMed Web of Science ®Google Scholar
• Cabibbe AM, Miotto P, Lazzeri Eet al.New DNA microarray platform platform for detection of MDR Mycobacterium tuberculosis and of drug-resistant malaria. Clin Microbiol Infect 2011;17 (Suppl 3): 591–592.
   Google Scholar
• Denkinger CM, Pai M.Using cerebrospinal fluid for the diagnosis of tuberculous meningitis with GeneXpert. Eur Respir J 2014;44: 1095–1096.
   PubMedGoogle Scholar
• Steingart KR, Schiller I, Horne DJet al.Xpert (R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014;21: 1–116.
   Google Scholar
• Baig S, Qayyum S, Saifullah Net al.Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB. Eur Respir J 2014;44: 2672.
   Web of Science ®Google Scholar
• Zhang Z, Li L, Luo Fet al.Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA gene chip: a prospective validation study. BMC Infect Dis 2012;12: 1–7.
   PubMed Web of Science ®Google Scholar
• Harris AD, Bradham DD, Baumgarten Met al.The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004;38: 1586–1591.
   PubMed Web of Science ®Google Scholar
• Geis S, Bettge-Weller G, Goetsch Uet al.How can we achieve better prevention of progression to tuberculosis among contacts? Eur Respir J 2013;42: 1743–1746.
   PubMed Web of Science ®Google Scholar
• Van Cutsem G, Isaakidis P, Farley Jet al.Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clin Infect Dis 2016;15 (Suppl 3): 238–243.
   Google Scholar
• Tortoli E, Russo C, Piersimoni Cet al.Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40: 442–447.
   PubMed Web of Science ®Google Scholar
• Lim TK, Chew MY, Ng Jet al.Xpert MTB/RIF testing of pooled induced sputum. Eur Respir J 2014;44: 2602.
   Web of Science ®Google Scholar
• Abubakar I, Zignol M, Falzon Det al.Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013;13: 529–539.
   PubMed Web of Science ®Google Scholar
• Nardell E.Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 2011;14: 1233–1243.
   Web of Science ®Google Scholar